Suppression of Tumorigenicity 2 in Heart Failure With Preserved Ejection Fraction.
AbouEzzeddine OF, McKie PM, Dunlay SM, Stevens SR, Felker GM, Borlaug BA, Chen HH, Tracy RP, Braunwald E, Redfield MM.
AbouEzzeddine OF, et al. Among authors: felker gm.
J Am Heart Assoc. 2017 Feb 18;6(2):e004382. doi: 10.1161/JAHA.116.004382.
J Am Heart Assoc. 2017.
PMID: 28214792
Free PMC article.
Clinical Trial.